Core Laboratories’ first quarter was marked by notable operational challenges, as the company faced disruptions from the conflict in the Middle East and severe weather across North America and Europe. These events led to project delays, facility closures, and reduced client activity, particularly impacting the Reservoir Description segment. CEO Lawrence Bruno attributed the margin pressure to “all the costs and none of the revenue,” as oil flows essential to the company’s services effectively halted. Management acknowledged the volatility and stated, “the situation remains unpredictable,” reflecting a cautious outlook amid ongoing geopolitical risks.
Is now the time to buy CLB? Find out in our full research report (it’s free for active Edge members).
Core Laboratories (CLB) Q1 CY2026 Highlights:
- Revenue: $121.8 million vs analyst estimates of $121 million (1.4% year-on-year decline, 0.7% beat)
- Adjusted EPS: $0.06 vs analyst expectations of $0.11 (45.5% miss)
- Adjusted EBITDA: $10.37 million vs analyst estimates of $12.79 million (8.5% margin, 18.9% miss)
- Operating Margin: 1.6%, down from 6.3% in the same quarter last year
- Market Capitalization: $656 million
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Core Laboratories’s Q1 Earnings Call
-
Donald Crist (Johnson Rice) asked whether Core Laboratories’ Middle East facilities were damaged and if operations would bounce back post-conflict. CEO Lawrence Bruno confirmed that infrastructure was undamaged and anticipated a strong rebound once oil flows resumed, but cautioned that timing depends on external factors.
-
Donald Crist (Johnson Rice) inquired about the disconnect between physical and paper oil markets and its impact on client urgency. Bruno noted that declining global inventories are encouraging national and international oil companies to prioritize energy security by developing resources closer to home.
-
Donald Crist (Johnson Rice) questioned the outlook for North Africa, referencing recent activity in Libya. Bruno described ongoing client engagement in North Africa and highlighted Core Laboratories’ readiness to support reservoir development and unconventional opportunities in the region.
-
Sean Mitchell (Daniel Energy Partners) asked about the complexity and potential duration of Middle East recovery timelines. Bruno explained that while infrastructure damage was limited, restoring production and logistics would require coordinated efforts, refilling reserves, and could be costly.
-
Sean Mitchell (Daniel Energy Partners) followed up on incremental demand for reservoir diagnostics during the recovery. Bruno confirmed operators are seeking Core Laboratories’ solutions to optimize production as fields return to service, with additional interest in diagnostics to accelerate catch-up production.
Catalysts in Upcoming Quarters
Looking forward, the StockStory team will monitor (1) the pace of normalization in Middle East client activity and oil trade flows, (2) further international project wins and expansion into North Africa and other emerging offshore markets, and (3) the rollout and adoption of digital reservoir data solutions. Continued management of supply chain and cost inflation, as well as progress in restoring damaged facilities, will also be important signposts for operational recovery.
Core Laboratories currently trades at $14.40, down from $17.30 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.